• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和成纤维细胞缺陷型中的丙酮酸脱氢酶复合物活性

Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.

作者信息

Sheu K F, Hu C W, Utter M F

出版信息

J Clin Invest. 1981 May;67(5):1463-71. doi: 10.1172/jci110176.

DOI:10.1172/jci110176
PMID:6262377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC370714/
Abstract

Pyruvate dehydrogenase complex (PDC) activity in human skin fibroblasts appears to be regulated by a phosphorylation-dephosphorylation mechanism, as is the case with other animal cells. The enzyme can be activated by pretreating the cells with dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase, before they are disrupted for measurement of PDC activity. With such treatment, the activity reaches 5-6 nmol/min per mg of protein at 37 degrees C with fibroblasts from infants. Such values represent an activation of about 5-20-fold over those observed with untreated cells. That this assay, based on [1-(14)C]pyruvate decarboxylation, represents a valid measurement of the overall PDC reaction is shown by the dependence of (14)CO(2) production on the presence of thiamin-PP, coenzyme A (CoA), Mg(++), and NAD(+). Also, it has been shown that acetyl-CoA and (14)CO(2) are formed in a 1:1 ratio. A similar degree of activation of PDC can also be achieved by adding purified pyruvate dehydrogenase phosphatase and high concentrations of Mg(++) and Ca(++), or in some cases by adding the metal ions alone to the cell homogenate after disruption. These results strongly suggest that activation is due to dephosphorylation. Addition of NaF, which inhibits dephosphorylation, leads to almost complete loss of PDC activity. Assays of completely activated PDC were performed on two cell lines originating from patients reported to be deficient in this enzyme (Blass, J. P., J. Avigan, and B. W. Ublendorf. 1970. J. Clin. Invest. 49: 423-432; Blass, J. P., J. D. Schuman, D. S. Young, and E. Ham. 1972. J. Clin. Invest. 51: 1545-1551). Even after activation with DCA, fibroblasts from the patients showed values of only 0.1 and 0.3 nmol/min per mg of protein. A familial study of one of these patients showed that both parents exhibited activity in fully activated cells about half that of normal values, whereas cells from a sibling appeared normal. These results demonstrate the inheritance nature of PDC deficiency, and that the present assay is sufficient to detect the heterozygous carriers of the deficiency. Application of the same procedures to fibroblasts obtained from 16 individuals who were believed to have normal PDC activities showed a range from about 2-2.5 nmol/min per mg protein for adults to 5-6 nmol/min per mg protein for cells from infants.

摘要

与其他动物细胞一样,人类皮肤成纤维细胞中的丙酮酸脱氢酶复合体(PDC)活性似乎受磷酸化-去磷酸化机制调控。在细胞破碎以测量PDC活性之前,用丙酮酸脱氢酶激酶抑制剂二氯乙酸(DCA)预处理细胞,可激活该酶。经此处理后,婴儿成纤维细胞在37℃下的活性达到每毫克蛋白质5 - 6 nmol/分钟。这些数值相较于未处理细胞观察到的数值,代表了约5 - 20倍的激活。基于[1-(14)C]丙酮酸脱羧的该测定法能有效测量PDC的整体反应,这体现在(14)CO(2)的产生依赖于硫胺素-PP、辅酶A(CoA)、Mg(++)和NAD(+)的存在。此外,已表明乙酰辅酶A和(14)CO(2)以1:1的比例形成。通过添加纯化的丙酮酸脱氢酶磷酸酶以及高浓度的Mg(++)和Ca(++),或者在某些情况下,在细胞破碎后向细胞匀浆中单独添加金属离子,也能实现类似程度的PDC激活。这些结果有力地表明激活是由于去磷酸化。添加抑制去磷酸化的NaF会导致PDC活性几乎完全丧失。对源自据报道该酶缺乏的患者的两个细胞系进行了完全激活的PDC测定(布拉斯,J.P.,J.阿维根,和B.W.乌布伦多夫。1970.《临床研究杂志》49: 423 - 432;布拉斯,J.P.,J.D.舒曼,D.S.扬,和E.哈姆。1972.《临床研究杂志》51: 1545 - 1551)。即便用DCA激活后,这些患者的成纤维细胞每毫克蛋白质的活性值仅为0.1和0.3 nmol/分钟。对其中一位患者的家族研究表明,父母双方在完全激活的细胞中的活性约为正常值的一半,而其一位兄弟姐妹的细胞看起来正常。这些结果证明了PDC缺乏的遗传性质,且目前的测定法足以检测该缺乏的杂合携带者。对从16名被认为具有正常PDC活性的个体获取的成纤维细胞应用相同程序,结果显示,成年人的活性范围约为每毫克蛋白质2 - 2.5 nmol/分钟,婴儿细胞的活性为每毫克蛋白质5 - 6 nmol/分钟。

相似文献

1
Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.正常和成纤维细胞缺陷型中的丙酮酸脱氢酶复合物活性
J Clin Invest. 1981 May;67(5):1463-71. doi: 10.1172/jci110176.
2
Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity.基于硫辛酰结构域的机制,通过增强丙酮酸脱氢酶激酶活性对丙酮酸脱氢酶复合体进行整合反馈控制。
J Biol Chem. 1996 Jan 12;271(2):653-62. doi: 10.1074/jbc.271.2.653.
3
The importance of pyruvate availability to PDC activation and anaplerosis in human skeletal muscle.丙酮酸可用性对人体骨骼肌中丙酮酸脱氢酶复合体激活和回补反应的重要性。
Am J Physiol. 1999 Mar;276(3):E472-8. doi: 10.1152/ajpendo.1999.276.3.E472.
4
TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts.TGF-β1 是成纤维细胞中丙酮酸脱氢酶复合物的调节因子。
Sci Rep. 2020 Oct 21;10(1):17914. doi: 10.1038/s41598-020-74919-8.
5
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.靶向丙酮酸脱氢酶复合物/丙酮酸脱氢酶激酶(PDC/PDK)轴治疗癌症。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx071.
6
Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: effects of pyruvate dehydrogenase complex deficiency and dichloroacetate.培养的人成纤维细胞中线粒体燃料代谢和能量学的磁共振波谱研究:丙酮酸脱氢酶复合物缺乏症和二氯乙酸的影响
Mol Genet Metab. 2006 Sep-Oct;89(1-2):97-105. doi: 10.1016/j.ymgme.2006.04.015. Epub 2006 Jun 12.
7
A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue.人体肌肉组织中丙酮酸脱氢酶复合物的灵敏放射性同位素测定法。
Anal Biochem. 1991 Nov 1;198(2):347-51. doi: 10.1016/0003-2697(91)90437-x.
8
Activation of pyruvate dehydrogenase complex by porcine and biosynthetic human insulin in cultured human fibroblasts.猪胰岛素和生物合成人胰岛素对培养的人成纤维细胞中丙酮酸脱氢酶复合体的激活作用。
Diabetes. 1984 Jul;33(7):681-5. doi: 10.2337/diab.33.7.681.
9
Detection of pyruvate metabolism disorders by culture of skin fibroblasts with dichloroacetate.用二氯乙酸培养皮肤成纤维细胞检测丙酮酸代谢紊乱
Pediatr Res. 1988 Jun;23(6):561-4. doi: 10.1203/00006450-198806000-00005.
10
Pigeon liver phosphoprotein phosphatase: an effective activator of pyruvate dehydrogenase in tissue homogenates.鸽肝磷酸蛋白磷酸酶:组织匀浆中丙酮酸脱氢酶的有效激活剂。
Arch Biochem Biophys. 1986 Apr;246(1):381-90. doi: 10.1016/0003-9861(86)90483-2.

引用本文的文献

1
Comprehensive analysis of regulated cell death pathways: intrinsic disorder, protein-protein interactions, and cross-pathway communication.细胞程序性死亡途径的综合分析:内在无序、蛋白质-蛋白质相互作用及跨途径通讯
Apoptosis. 2025 Aug 19. doi: 10.1007/s10495-025-02161-6.
2
Nanoparticles induced cuproptosis to enhance antitumor immunotherapy.纳米颗粒诱导铜死亡以增强抗肿瘤免疫治疗。
J Nanobiotechnology. 2025 Jul 28;23(1):544. doi: 10.1186/s12951-025-03616-3.
3
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer.癌症中铜及铜死亡的分子机制与治疗前景
Signal Transduct Target Ther. 2025 May 9;10(1):149. doi: 10.1038/s41392-025-02192-0.
4
Cuproptosis in lung cancer: mechanisms and therapeutic potential.肺癌中的铜死亡:机制与治疗潜能。
Mol Cell Biochem. 2024 Jun;479(6):1487-1499. doi: 10.1007/s11010-023-04815-y. Epub 2023 Jul 22.
5
Cuproptosis: mechanisms and links with cancers.铜死亡:机制与癌症的关联。
Mol Cancer. 2023 Mar 7;22(1):46. doi: 10.1186/s12943-023-01732-y.
6
Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency.二氯乙酸盐与苯丁酸钠盐治疗丙酮酸脱氢酶缺乏症的比较。
Br J Biomed Sci. 2022 May 19;79:10382. doi: 10.3389/bjbs.2022.10382. eCollection 2022.
7
Arrangement and symmetry of the fungal E3BP-containing core of the pyruvate dehydrogenase complex.丙酮酸脱氢酶复合体含真菌E3BP核心的排列与对称性。
Nat Commun. 2020 Sep 16;11(1):4667. doi: 10.1038/s41467-020-18401-z.
8
Pitfalls of relying on genetic testing only to diagnose inherited metabolic disorders in non-western populations - 5 cases of pyruvate dehydrogenase deficiency from South Africa.仅依靠基因检测诊断非西方人群遗传性代谢疾病的陷阱——来自南非的5例丙酮酸脱氢酶缺乏症病例
Mol Genet Metab Rep. 2020 Jul 22;24:100629. doi: 10.1016/j.ymgmr.2020.100629. eCollection 2020 Sep.
9
Phenotypic variability in deficiency of the α subunit of succinate-CoA ligase.琥珀酰辅酶A连接酶α亚基缺乏症的表型变异性。
JIMD Rep. 2019 Mar 14;46(1):63-69. doi: 10.1002/jmd2.12018. eCollection 2019 Mar.
10
Bi-allelic mutations of LONP1 encoding the mitochondrial LonP1 protease cause pyruvate dehydrogenase deficiency and profound neurodegeneration with progressive cerebellar atrophy.LONP1 编码线粒体 LonP1 蛋白酶的双等位基因突变导致丙酮酸脱氢酶缺乏症和进行性小脑萎缩的严重神经退行性变。
Hum Mol Genet. 2019 Jan 15;28(2):290-306. doi: 10.1093/hmg/ddy351.

本文引用的文献

1
Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (Short Communication).二氯乙酸对灌流大鼠心脏丙酮酸脱氢酶的激活(简短通讯)。
Biochem J. 1973 Jun;134(2):651-3. doi: 10.1042/bj1340651.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
Biochemical mechanisms of biotin and thiamin action and relationships to genetic disease.
Birth Defects Orig Artic Ser. 1980;16(1):289-304.
4
Clinical studies of a patient with pyruvate decarboxylase deficiency.一名丙酮酸脱羧酶缺乏症患者的临床研究。
Arch Neurol. 1971 Nov;25(5):449-60. doi: 10.1001/archneur.1971.00490050083007.
5
Function of the nonidentical subunits of mammalian pyruvate dehydrogenase.哺乳动物丙酮酸脱氢酶不同亚基的功能。
Biochem Biophys Res Commun. 1972 Aug 21;48(4):840-6. doi: 10.1016/0006-291x(72)90684-5.
6
Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids.二氯乙酸及其他卤代羧酸激活丙酮酸脱氢酶的机制。
Biochem J. 1974 Sep;141(3):761-74. doi: 10.1042/bj1410761.
7
Regulation of heart muscle pyruvate dehydrogenase kinase.心肌丙酮酸脱氢酶激酶的调节
Biochem J. 1974 Dec;143(3):625-41. doi: 10.1042/bj1430625.
8
-Keto acid dehydrogenase complexes. XV. Purification and properties of the component enzymes of the pyruvate dehydrogenase complexes from bovine kidney and heart.-酮酸脱氢酶复合体。十五。牛肾和心脏丙酮酸脱氢酶复合体组成酶的纯化及性质
Arch Biochem Biophys. 1972 Feb;148(2):327-42. doi: 10.1016/0003-9861(72)90151-8.
9
Calcium and magnesium ions as effectors of adipose-tissue pyruvate dehydrogenase phosphate phosphatase.钙和镁离子作为脂肪组织丙酮酸脱氢酶磷酸磷酸酶的效应物。
Biochem J. 1974 May;140(2):225-37. doi: 10.1042/bj1400225.
10
Monovalent cation requirement for ADP inhibition of pyruvate dehydrogenase kinase.ADP抑制丙酮酸脱氢酶激酶对单价阳离子的需求。
Biochem Biophys Res Commun. 1974 Aug 19;59(4):1341-8. doi: 10.1016/0006-291x(74)90461-6.